Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10086308 | 0.77 | ALOX15 (0.35) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18789479 | 0.68 | ALOX15 (0.39) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22053555 | 0.68 | ALOX15 (0.39) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL12896580 | 0.68 | ALOX15 (0.39) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24245829 | 0.66 | ALDH1A1 (0.33) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL8739817 | 0.65 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18789464 | 0.64 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18827095 | 0.63 | ALOX15 (0.40) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18827057 | 0.62 | ALOX15 (0.36) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL10086112 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091723-B2 | Use of ambrocenide® for intensifying a lily of the valley scent | SYMRISE AG (DE) | 2021-08-17 | — | — | US | disclosed |
| US-20200239810-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | SYMRISE AG (DE) | 2020-07-30 | — | — | US | disclosed |
| EP-2287158-B1 | Ambergris Odorous Substance based on 9-Methanoazuleno(5,6-d)-1,3-dioxoles | SYMRISE AG (DE) | 2012-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239810-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | OR51E2, OR10J3, ALG3 | ALOX15 710/4885ALDH1A1 1767/4885LMNA 3395/4885 |
| US-11091723-B2 | Use of ambrocenide® for intensifying a lily of the valley scent | OR51E2, OR10J3, TRPA1 | ALOX15 585/4885ALDH1A1 1494/4885LMNA 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.